Pediatric critical asthma is one of the most frequent reasons for presentation to the emergency department and admission to the floor or pediatric ICU (PICU) in pediatric patients. Clinical pathways and protocols have been used frequently in respiratory care, and many have been associated with an improvement in outcomes. We performed a systematic review on the use of protocols or pathways in the treatment of critical asthma.
Methods:
MEDLINE, Embase, and CINAHL were searched with no date limits; last search was completed in July 2024 to identify randomized controlled trials, crossover studies, observational studies, and quality improvement (QI) studies comparing the use of a protocol or pathway in the treatment of pediatric critical asthma to the standard of care. Abstracts were screened by a subgroup of the clinical practice guidelines committee, and subsequently full-text articles were screened and data were extracted. A fixed-effect meta-analysis was performed for each outcome.
Results:
We included 23 studies, with the majority being observational or QI studies. The outcomes included in this analysis were hospital stay, PICU stay, intubation rate, noninvasive respiratory support (NRS) usage, and rate of escalation of respiratory support. Use of clinical pathways and/or protocols was associated with a shorter hospital stay (mean difference [MD] −0.77 d [95% CI −0.81 to −0.73]) and PICU stay (MD −0.31 d [95% CI −0.37 to −0.26]). There was a decreased incidence of the need for increased respiratory support (odds ratio [OR] 0.59 [95% CI 0.39–0.59]). There was no change in the need for intubation (OR 0.4 [95% CI 0.12–1.34]) or incidence of NRS usage (OR 1.12 [95% CI 0.76–1.63]).
Conclusions:
Pediatric asthma protocols were associated with reductions in hospital stay, PICU stay, and decreased need for respiratory support escalation but not intubation or NRS use.
Get full access to this article
View all access options for this article.
References
1.
PerryR, BraileanuG, PalmerT, et al.The economic burden of pediatric asthma in the United States: Literature review of current evidence. Pharmacoeconomics, 2019; 37(2):155–167; doi: 10.1007/s40273-018-0726-2
SolIS, JangH, NohJ, et al.Mortality and morbidity in children with asthma: A nationwide study in Korea. Respir Med, 2021; 177:106306; doi: 10.1016/j.rmed.2021.106306
4.
MukherjeeM, CunninghamS, BhuiaMR, et al.Asthma in paediatric intensive care in England residents: observational study. Sci Rep, 2022; 12(1):1315; doi: 10.1038/s41598-022-05414-5
5.
CraigS, PowellCVE, NixonGM, et al.Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) Multicentre Cohort Study. BMJ Open Respir Res, 2022; 9(1):e001137; doi: 10.1136/bmjresp-2021-001137
6.
CloutierMM, BaptistAP, WalshCG, et al.; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 focused updates to the asthma management guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol, 2020; 146(6):1217–1270; doi: 10.1016/j.jaci.2020.10.003
7.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024. 2024. Available from www.ginasthma.org [Last accessed: Oct30, 2024].
8.
MaueDK, EalyA, HobsonMJ, et al.Improving outcomes for bronchiolitis patients After implementing a high-flow nasal cannula holiday and standardizing discharge criteria in a PICU. Pediatr Crit Care Med, 2023; 24(3):233–242; doi: 10.1097/PCC.0000000000003183
9.
Abu-SultanehS, HoleAJ, ToriAJ, et al.An interprofessional quality improvement initiative to standardize pediatric extubation readiness assessment. Pediatr Crit Care Med, 2017; 18(10):e463–e471; doi: 10.1097/PCC.0000000000001285
10.
RogersonCM, ToriAJ, HoleAJ, et al.Reducing unnecessary nitric oxide use: A hospital-wide, respiratory therapist-driven quality improvement project. Respir Care, 2021; 66(1):18–24; doi: 10.4187/respcare.08347
11.
MalinSW, MaueDK, CaterDT, et al.A Quality Improvement initiative to reduce unnecessary screening chest radiographs in a pediatric ICU. Respir Care, 2023; 68(10):1377–1384; doi: 10.4187/respcare.10689
12.
WhiteB, MillerAG, Abu-SultanehS, et al.AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma. Respir Care, 2025; 70(5):593–609; doi: 10.1089/respcare.12897
13.
HarrisPA, TaylorR, ThielkeR, et al.Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 2009; 42(2):377–381; doi: 10.1016/j.jbi.2008.08.010
14.
HarrisPA, TaylorR, MinorBL, et al.; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform, 2019; 95:103208; doi: 10.1016/j.jbi.2019.103208
15.
ViechtbauerW. Conducting meta-analyses in R with the metafor package. J Stat Soft, 2010; 36(3):1–48; doi: 10.1863/7/jss.v036.i03
16.
GuyattG, OxmanAD, AklEA, et al.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol, 2011; 64(4):383–394; doi: 10.1016/j.jclinepi.2010.04.026
17.
SchünemannH. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. The GRADE Working Group; 2013. Available from: https://gdt.gradepro.org/app/handbook/handbook.html [Last accessed: Nov15, 2024].
18.
McMaster University, Prime E. GRADEpro GDT: GRADEpro Guideline Development Tool 2021. Available from: gradepro.org [Last accessed: Nov30, 2024].
19.
SchunemannHJ, JaeschkeR, GuyattG, et al.; ATS Documents Development and Implementation Committee. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med, 2006; 174(5):605–614; doi: 10.1164/rccm.200602-197ST
20.
SterneJAC, SavovicJ, HigginsJPT, et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj, 2019; 366:l4898; doi: 10.1136/bmj.l4898
21.
SterneJA, HernanMA, HigginsJP, et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj, 2016; 355:i4919; doi: 10.1136/bmj.i4919
22.
LierlMB, PettinichiS, SebastianKD, et al.Trial of a therapist-directed protocol for weaning bronchodilator therapy in children with status asthmaticus. Respir Care, 1999; 44(5):497–505.
23.
CunninghamS, LoganC, LockerbieL, et al.Effect of an integrated care pathway on acute asthma/wheeze in children a2ttending hospital: cluster randomized trial. J Pediatr, 2008; 152(3):315–320; doi: 10.1016/j.jpeds.2007.09.033
24.
WongJ, AgusMSD, GrahamDA, et al.A critical asthma standardized clinical and management plan reduces duration of critical asthma therapy. Hosp Pediatr, 2017; 7(2):79–87; doi: 10.1542/hpeds.2016-0087
25.
MagruderTG, NarayananS, WalleyS, et al.Improving inpatient asthma management: The implementation and evaluation of a pediatric asthma clinical pathway. Pediatr Qual Saf, 2017; 2(5):e041; doi: 10.1097/pq9.0000000000000041
26.
BartlettKW, ParenteVM, MoralesV, et al.Improving the efficiency of care for pediatric patients hospitalized with asthma. Hosp Pediatr, 2017; 7(1):31–38; doi: 10.1542/hpeds.2016-0108
27.
MaueDK, ToriAJ, BeardsleyAL, et al.Implementing a respiratory therapist-driven continuous albuterol weaning protocol in the pediatric ICU. Respir Care, 2019; 64(11):1358–1365; doi: 10.4187/respcare.06447
28.
SmithA, BanvilleD, GruverEJ, et al.A clinical pathway for the care of critically ill patients with asthma in the community hospital setting. Hosp Pediatr, 2019; 9(3):179–185; doi: 10.1542/hpeds.2018-0197
29.
MillerAG, HaynesKE, GatesRM, et al.A respiratory therapist-driven asthma pathway reduced hospital length of stay in the pediatric intensive care unit. Respir Care, 2019; 64(11):1325–1332; doi: 10.4187/respcare.06626
30.
ShakirahMS, JamalludinAR, HasniahAL, et al.Paediatric asthma clinical pathway: Impact on cost and quality of care. Med J Malaysia, 2019; 74(2):138–144.
31.
MelendezE, DwyerD, DonellyD, et al.Standardized protocol is associated with a decrease in continuous albuterol use and length of stay in critical status asthmaticus. Pediatr Crit Care Med, 2020; 21(5):451–460; doi: 10.1097/PCC.0000000000002239
32.
KucherNM, S DhaliwalD, FischerGA, et al.Implementation of a critical asthma protocol in a pediatric ICU. Respir Care, 2021; 66(4):635–643; doi: 10.4187/respcare.07944
33.
MiksaM, KaushikS, AntovertG, et al.Implementation of a critical care asthma pathway in the PICU. Crit Care Explor, 2021; 3(2):e0334; doi: 10.1097/CCE.0000000000000334
34.
FlahertyMR, WhalenK, LeeJ, et al.Implementation of a nurse-driven asthma pathway in the pediatric intensive care unit. Pediatr Qual Saf, 2021; 6(6):e503; doi: 10.1097/pq9.0000000000000503
35.
MaueDK, CaterDT, RogersonCM, et al.Outcomes of a respiratory therapist driven high flow nasal cannula management protocol for pediatric critical asthma patients. Pediatr Pulmonol, 2023; 58(10):2881–2888; doi: 10.1002/ppul.26606
36.
LopezM, WilsonM, CobbinaE, et al.Decreasing ICU and hospital length of stay through a standardized respiratory therapist-driven electronic clinical care pathway for status asthmaticus. Pediatr Qual Saf, 2023; 8(6):e697; doi: 10.1097/pq9.0000000000000697
37.
KellyCS, AndersenCL, PestianJP, et al.Improved outcomes for hospitalized asthmatic children using a clinical pathway. Ann Allergy Asthma Immunol, 2000; 84(5):509–516; doi: 10.1016/S1081-1206(10)62514-8
38.
CarrollCL, SchrammCM. Protocol-based titration of intravenous terbutaline decreases length of stay in pediatric status asthmaticus. Pediatr Pulmonol, 2006; 41(4):350–356; doi: 10.1002/ppul.20394
39.
PhillipsM, FahrenbachJ, KhanolkarM, et al.The effect of a pediatric intensive care severity-tiered pathway for status asthmaticus on quality measures and outcomes. Pediatr Allergy Immunol Pulmonol, 2017; 30(4):246–251; doi: 10.1089/ped.2017.0777
40.
BrennanS, LowrieL, WooldridgeJ. Effects of a PICU status asthmaticus de-escalation pathway on length of stay and albuterol use. Pediatr Crit Care Med, 2018; 19(7):658–664; doi: 10.1097/PCC.0000000000001551
41.
OkadaY, NakamuraT, MaedaM, et al.Utility of therapeutic strategy based on the modified Pulmonary Index Score for childhood asthma exacerbation. Allergy Asthma Proc, 2019; 40(2):111–115; doi: 10.2500/aap.2019.40.4203
42.
SjoerdsmaMH, BongaertsTHG, van LenteL, et al.Nurse-driven clinical pathway based on an innovative asthma score reduces admission time for children. Pediatr Qual Saf, 2020; 5(5):e344; doi: 10.1097/pq9.0000000000000344
43.
JohnsonKB, BlaisdellCJ, WalkerA, et al.Effectiveness of a clinical pathway for inpatient asthma management. Pediatrics, 2000; 106(5):1006–1012; doi: 10.1542/peds.106.5.1006
44.
McDowellKM, ChatburnRL, MyersTR, et al.A cost-saving algorithm for children hospitalized for status asthmaticus. Arch Pediatr Adolesc Med, 1998; 152(10):977–984; doi: 10.1001/archpedi.152.10.977
45.
MillerAG, BurrKL, JubyJ, et al.Enhancing respiratory therapists’ well-being: Battling burnout in respiratory care. Respir Care, 2023; 68(5):692–705; doi: 10.4187/respcare.10632
46.
MillerAG, RobertsKJ, SmithBJ, et al.; American Association collaborators. Prevalence of burnout among respiratory therapists amidst the COVID-19 pandemic. Respir Care, 2021; 66(11):1639–1648; doi: 10.4187/respcare.09283
47.
DexheimerJW, BoryckiEM, AronskyD, et al.A systematic review of the implementation and impact of asthma protocols. BMC Med Inform Decis Mak, 2014; 14:82; doi: 10.1186/1472-6947-14-82
48.
ChenKH, ChenCC, GlasziouPP, et al.Effectiveness of paediatric asthma clinical pathways: a narrative systematic review. J Asthma, 2014; 51(5):480–492; doi: 10.3109/02770903.2014.887728
49.
MillerAG, RottaAT. Noninvasive respiratory support for pediatric critical asthma. Respir Care, 2025; 70(6):760–776; doi: 10.4187/respcare.12487
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
